3197 results for «800»
3197 results
TAVI and alternative access
19 Feb 2023 – From PCR Tokyo Valves 2023
Learn more about TAVI in this session by reviewing case submissions on topics such as bailout transseptal approach, primary percutaneous transaxillary TAVI, and transapical TAVI with chimney stenting.
Imaging for structural heart disease intervention
19 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session if you want to learn about imaging in structural heart interventions by exploring series of slides on restoration post transcatheter mitral valve repair, diagnostic performance of CT angiography, and AI in aortic complex measurement for TAVI, and more!
Other cardiac interventions
19 Feb 2023 – From PCR Tokyo Valves 2023
Explore innovative approaches to cardiac interventions featured at PCR Tokyo Valves 2023: from performing TricValve implantation in Asian patients to addressing unique cases like transcatheter valve replacement with a novel tricuspid bioprosthesis. Discover how these experts navigated challenging scenarios!
TAVI in patients with heavily calcified aortic root
19 Feb 2023 – From PCR Tokyo Valves 2023
What role does TAVI play in patients' severely calcified roots? Study the use of balloon-expandable devices, assessing the impact of calcification on aortic root rupture, strategies for safe and effective procedures, and when to consider surgical AVR.
Mitral valve implantation and other technology
19 Feb 2023 – From PCR Tokyo Valves 2023
This session offers insight into advanced mitral valve technologies. It covers details of transapical off-pump repair with synthetic chordae, India's success in transcatheter double valve-in-valve, TMVI in failing valves, and more.
Coronary access after TAVI
19 Feb 2023 – From PCR Tokyo Valves 2023
Unlock insights into post-TAVI coronary access. Understand transcatheter aortic valve structure, neo-commissure anatomy, and practical techniques. This session covers topics such as optimising commissure alignment, elective CAG/PCI, ACS, and severe aortic stenosis.
How should the clinical data on TAVI durability impact the clinical practice?
10 Mar 2021
Watch this PCR Webinar with L. Sondergaard, D. Capodanno, M. Reardon.
Acute outcomes for the full US cohort of the FLASH Mechanical Thrombectomy Registry in pulmonary embolism
21 Sep 2022
Waqar Ahmed provides his take on the FLASH Mechanical Thrombectomy Registry which was presented by Catalin Toma at TCT 2022.
The article was simultaneously published in the EuroIntervention Journal: Acute Outcomes for the Full US Cohort of the FLASH Mechanical Thrombectomy Registry in Pulmonary Embolism. EuroIntervention, C. Toma et al. DOI:...
Author
Vesalio Announces the Completion of Enrollment in Its FDA IDE Clinical Study for Acute Ischemic Stroke
11 May 2022
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE Aapproval , its Fourth FDA IDE DEB approval
10 Jan 2023
Robocath performs world’s First-In-Human remote robotic coronary angioplasty between two Chinese cities 1,700 miles apart
14 Dec 2023
SMT Announces Completion of Patient Enrolment for TUXEDO-2 Trial
16 Aug 2024
MedAlliance leads US Sirolimus DEB race: first US patient enrolled into SELUTION SLR coronary sirolimus DEB study
25 Jan 2023
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
SMT’s Supraflex Cruz shows consistent and robust clinical outcomes across key global studies presented at TCT 2025
29 Oct 2025
Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial
31 Aug 2021
Luigi Biasco reports the best of Dj Lakkireddy (Overland Park, USA)'s presentation of the AMULET IDE trial at the Monday, August 30 Hot Line session of the ESC Congress 2021.
Author
Fractional flow reserve-guided complete or culprit-only PCI in patients with ST-elevation myocardial Infarction - FULL REVASC
08 Apr 2024
Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.
The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...
Author
